Lumenato™ Receives EFSA Approval: A New Chapter for Ingestible Skincare Innovation

Lycored is proud to announce that the European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods and Food Allergens has issued a positive scientific opinion on Lumenato™, affirming its safety as a novel food. This milestone opens the door for Lumenato’s expansion into the European Union and strengthens its global positioning as a clinically supported, ingestible skincare solution.

What Is Lumenato™?

Lumenato™ is a natural, ingestible skincare ingredient derived from Lycored’s proprietary breed of golden tomatoes. These tomatoes are specially cultivated for their beauty-enhancing properties, delivering a synergistic blend of carotenoids and essential nutrients that support skin structure, healthy cell signaling, and the process of graceful aging.

More than just a natural extract, Lumenato is a vegan collagen booster and a powerful skin defender. It promotes the appearance of youthful, radiant skin—backed by science, not just promises.

Clinically Proven Skin Benefits

Lumenato™ is formulated using a lipid-based extraction method that enhances bioavailability and efficacy, allowing the body to build a “reservoir of goodness” that delivers skin-active nutrients where they’re needed most.

In a recent clinical study involving 60 healthy women aged 35–55, participants took a daily Lumenato supplement for 12 weeks. The results were compelling:

In 2022, additional research confirmed that Lumenato complements collagen by nourishing the skin’s internal environment, enhancing its natural resilience, and supporting collagen’s structural benefits—making it a perfect partner in any holistic beauty routine.

What EFSA Approval Means

EFSA’s positive scientific opinion confirms that Lumenato meets the stringent safety and quality standards required for novel foods in the EU. This approval allows Lumenato to be legally marketed and incorporated into food, beverage, and supplement products across all EU member states.

For nutraceutical brands, this opens the door to:

  • Product innovation: Lumenato can now be formulated into a wide range of ingestible beauty products, from capsules and softgels to functional beverages and gummies.
  • Clean-label positioning: As a plant-based, clinically supported ingredient, Lumenato aligns with growing consumer demand for transparency, sustainability, and natural efficacy.
  • Regulatory confidence: EFSA’s rigorous evaluation process adds a layer of credibility that can support claims and marketing efforts across regulated markets.

Expanding Beyond Europe

While EFSA approval specifically applies to the EU, it also strengthens Lumenato’s global reputation. Regulatory bodies in other regions often look to EFSA as a benchmark, which can:

  • Accelerate approvals in other markets such as Latin America and the Middle East.
  • Support cross-border partnerships with global supplement brands and formulators.
  • Enhance investor and stakeholder confidence in the ingredient’s safety, efficacy, and scalability.

A Strategic Advantage for Early Adopters

Brands that incorporate Lumenato now can position themselves as leaders in the ingestible skincare space, leveraging its unique golden tomato origin, vegan collagen-boosting properties, and clinical backing. With the ingestible beauty market projected to grow significantly in the coming years, EFSA approval gives early adopters a competitive edge in both product development and consumer trust.

Continue reading

Nature based solutions to replace artificial colors

Consumer awareness of food, health, and other household products is growing and with that, the demand for naturally derived, plant-based colors is soaring.

Meeting Consumer Demands and Nutraceutical Trends with Lycomato⁶™

Supplements aren’t going anywhere, and with bustling nutraceutical trends, manufacturers need to keep on top of consumer demands. Understanding Today’s Nutraceutical Trends and Consumer The supplements industry has gone through...

FDA Red 3 Ban

Deep Dive: FDA to revoke Red No. 3 authorization

January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.

We're here for you

Interested in speaking directly with a member of our team?
Click below to get in touch.

Contact us